These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18473923)

  • 1. Recent advances in antiviral agents: established and innovative therapies for viral hepatitis.
    Balsano C
    Mini Rev Med Chem; 2008 Apr; 8(4):307-18. PubMed ID: 18473923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatitis B and C: From molecular virology to new antiviral therapies (part 1)].
    Thimme R; Heim M; Baumert TF; Nassal M; Moradpour D
    Dtsch Med Wochenschr; 2014 Mar; 139(13):655-9. PubMed ID: 24648178
    [No Abstract]   [Full Text] [Related]  

  • 3. Viral hepatitis B: established and emerging therapies.
    Balsano C; Alisi A
    Curr Med Chem; 2008; 15(9):930-9. PubMed ID: 18473801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
    Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
    Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus.
    Gentile I; Zappulo E; Buonomo AR; Borgia G
    Expert Rev Anti Infect Ther; 2014 Jul; 12(7):775-82. PubMed ID: 24840817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral hepatitis. From prevention to antivirals.
    Jonas MM
    Clin Liver Dis; 2000 Nov; 4(4):849-77. PubMed ID: 11232361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucosidase inhibitors as antiviral agents for hepatitis B and C.
    Durantel D; Alotte C; Zoulim F
    Curr Opin Investig Drugs; 2007 Feb; 8(2):125-9. PubMed ID: 17328228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Association for the Study of Liver Diseases (AASLD)--56th Annual Meeting.
    Phend C
    IDrugs; 2006 Feb; 9(2):96-100. PubMed ID: 16523396
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis viruses and liver transplantation.
    Samuel D; Feray C; Bismuth H
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection.
    Degasperi E; Caprioli F; El Sherif O; Back D; Colombo M; Aghemo A
    Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1373-1383. PubMed ID: 27718758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral hepatitis at a crossroad.
    Lok AS; Pawlotsky JM
    Gastroenterology; 2012 May; 142(6):1261-3. PubMed ID: 22537431
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.
    Liu CJ
    J Gastroenterol Hepatol; 2014 Jan; 29(1):26-30. PubMed ID: 24199625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B and hepatitis C in 2009.
    Marcellin P
    Liver Int; 2009 Jan; 29 Suppl 1():1-8. PubMed ID: 19207959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridging basic science and clinical research: the EASL Monothematic Conference on Translational Research in Viral Hepatitis.
    Boettler T; Moradpour D; Thimme R; Zoulim F
    J Hepatol; 2014 Sep; 61(3):696-705. PubMed ID: 24845610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative review of HLA associations with hepatitis B and C viral infections across global populations.
    Singh R; Kaul R; Kaul A; Khan K
    World J Gastroenterol; 2007 Mar; 13(12):1770-87. PubMed ID: 17465466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral therapies for managing viral hepatitis in lymphoma patients.
    Merli M; Rattotti S; Gotti M; Arcaini L
    Expert Opin Pharmacother; 2017 Mar; 18(4):363-376. PubMed ID: 28140702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral Medication in Sexually Transmitted Diseases. Part III: Hepatitis B, Hepatitis C.
    Majewska A; Mlynarczyk-Bonikowska B; Malejczyk M; Majewski S; Mlynarczyk G
    Mini Rev Med Chem; 2017; 17(4):328-337. PubMed ID: 27515715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for the management of prevention of vertical HBV and HCV infection.
    Pawłowska M; Sobolewska-Pilarczyk M
    Przegl Epidemiol; 2016; 70(1):33-4, 119-20. PubMed ID: 27344471
    [No Abstract]   [Full Text] [Related]  

  • 20. Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin.
    Potthoff A; Berg T; Wedemeyer H;
    Scand J Gastroenterol; 2009; 44(12):1487-90. PubMed ID: 19900055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.